Literature DB >> 25730284

Screening of esophageal varices by esophageal capsule endoscopy: results of a French multicenter prospective study.

Sylvie Sacher-Huvelin1, Paul Calès2, Christophe Bureau3, Dominique Valla4, Jean Pierre Vinel3, Clotilde Duburque5, Alain Attar4, Isabelle Archambeaud6, Robert Benamouzig7, Marianne Gaudric8, Dominique Luet2, Patrice Couzigou9, Lucie Planche10, Jean Paul Galmiche6, Emmanuel Coron6.   

Abstract

BACKGROUND AND STUDY AIM: Esophageal video capsule endoscopy (ECE) is a new technique that allows examination of the esophagus using a noninvasive approach. The aim of this study was to compare ECE with esophagogastroduodenoscopy (EGD) for the diagnosis of esophageal varices in patients with cirrhosis. PATIENTS AND METHODS: A total of 330 patients with cirrhosis and with no known esophageal varices were prospectively enrolled. Patients underwent ECE first, followed by EGD (gold standard). The endoscopists who performed EGD were blind to the ECE result. Patient satisfaction was assessed using a visual analog scale (maximum score 100).
RESULTS: A total of 30 patients were excluded from the analysis because they did not undergo any endoscopic examinations. Patients (mean age 56 years; 216 male) had mainly alcoholic (45 %) or viral (27 %) cirrhosis. The diagnostic indices of ECE to diagnose and correctly stage esophageal varices were: sensitivity 76 % and 64 %, specificity 91 % and 93 %, positive predictive value 88 % and 88 %, and negative predictive value 81 % and 78 %, respectively. ECE patient satisfaction scored significantly higher than EGD (87 ± 22 vs. 58 ± 35; P < 0.0001).
CONCLUSIONS: ECE was well tolerated and safe in patients with liver cirrhosis and suspicion of portal hypertension. The sensitivity of ECE is not currently sufficient to replace EGD as a first exploration in these patients. However, due to its excellent specificity and positive predictive value, ECE may have a role in cases of refusal or contraindication to EGD. ECE might also improve compliance to endoscopic follow-up and aid important therapeutic decision making in the prophylaxis of bleeding. TRIAL REGISTRATION: EudraCT (ID RCB 2009-A00532-55) and ClinicalTrials.gov (NCT00941421). © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 25730284     DOI: 10.1055/s-0034-1391393

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  5 in total

Review 1.  Use of Wireless Capsule Endoscopy for the Diagnosis and Grading of Esophageal Varices in Patients With Portal Hypertension: A Systematic Review and Meta-Analysis.

Authors:  Thomas R McCarty; Yuliya Afinogenova; Basile Njei
Journal:  J Clin Gastroenterol       Date:  2017-02       Impact factor: 3.062

Review 2.  Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update.

Authors:  Federico Ravaioli; Marco Montagnani; Andrea Lisotti; Davide Festi; Giuseppe Mazzella; Francesco Azzaroli
Journal:  Gastroenterol Res Pract       Date:  2018-06-07       Impact factor: 2.260

Review 3.  Νon-invasive screening for esophageal varices in patients with liver cirrhosis.

Authors:  Andreas Karatzas; Christos Konstantakis; Ioanna Aggeletopoulou; Christina Kalogeropoulou; Konstantinos Thomopoulos; Christos Triantos
Journal:  Ann Gastroenterol       Date:  2018-03-03

4.  Current and Future Use of Esophageal Capsule Endoscopy.

Authors:  Junseok Park; Young Kwan Cho; Ji Hyun Kim
Journal:  Clin Endosc       Date:  2018-07-31

5.  Detachable string magnetically controlled capsule endoscopy for detecting high-risk varices in compensated advanced chronic liver disease (CHESS1801): A prospective multicenter study.

Authors:  Shuai Wang; Yifei Huang; Weiling Hu; Hua Mao; Mark Edward McAlindon; Yanna Liu; Li Yang; Chunqing Zhang; Ming Xu; Chaohui He; Tong Dang; Bin Wu; Dong Ji; Liting Zhang; Xiaorong Mao; Lei Zhang; Chuan Liu; Dan Xu; Yasong Li; Guoan Li; Juqiang Han; Fangfang Lv; Xiao Liang; Shaoqin Jin; Shaoheng Zhang; Foong Way David Tai; Qing Xu; Changqing Yang; Guangchuan Wang; Lifen Wang; Bo Li; Haiyun Yang; Ping Xie; Lulin Deng; Limei Ren; Zhiheng Chang; Xing Wang; Shan Wang; Xiaoqin Gao; Junfeng Li; Longdong Zhu; Fangzhao Wang; Lingen Zhang; Guo Zhang; Xi Jiang; Jun Pan; Wenbo Meng; Xun Li; Jinlin Hou; Xavier Dray; Zhuan Liao; Xiaolong Qi
Journal:  Lancet Reg Health West Pac       Date:  2020-12-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.